Summary
Efforts of GSK can be rewarding for indian patients by introducing Relenza in India, as it will help many infections like influenza.
Analysis
Influenza Management will be revolutionized by introduction of Relenza for indian patients by efforts of GSK, keeping in view the threat of Swine Flu.As specific drugs are lacking in the market.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
